| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.4136 | 19 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.6579 | 47 |
| GSM780709 | Untreated after 4 days (C3_1) | 45.496 | 30 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.1259 | 49 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.8226 | 54 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.3284 | 34 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.1004 | 49 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.4085 | 29 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.2612 | 28 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.0344 | 32 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.3826 | 34 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.6497 | 44 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.9475 | 27 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 39.9533 | 6 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.2962 | 58 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 54.5242 | 59 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 52.1619 | 54 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.6426 | 40 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.8654 | 48 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.3043 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 51.8689 | 54 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 51.2105 | 52 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.4773 | 43 |